Categories: Uncategorized

US announces USD 122 million fund for India to address challenges posed by infectious diseases

The United States has announced a financing of USD 122 million to top three Indian medical research institutes to prevent preventable epidemics, early identification of disease risks, and prompt and efficient response. The entire funding of USD 122,475,000 will be awarded over a five-year period to the three leading Indian health research institutions: the Indian Council of Medical Research (ICMR), the National Institute of Virology (NIV), and the National Institute of Epidemiology (NIE).

Announced by the Centres for Disease Control and Prevention (CDC) on Wednesday, the fund will accelerate the progress towards an India which is safe and secure from infectious disease threats through ICMR institutions’ focus on emerging and re-emerging pathogens. Prominent among these include detecting and controlling zoonotic disease outbreaks through a ‘one health’ approach; evaluating vaccine safety monitoring systems; capacitating the public health workforce in field epidemiology and outbreak response; and combating antimicrobial resistance, a media release said. CDC said ICMR is in a unique position to conduct this work, as it was originally established as an apex body for the formulation, coordination and promotion of biomedical research in India, and has taken up most of the laboratory-based surveillance of infectious diseases in recent years.

Also Read: Young men account for 60 per cent of all cardiology health queries: Practo

Funding is only available to ICMR and ICMR institutes from September 30, 2022, including the National Institute of Virology (NIV) in Pune and the National Institute of Epidemiology (NIE) in Chennai. The ICMR serves as the governing organisation for a number of national level institutes that are centres of excellence and reference in various scientific areas for India, including the National Institute of Virology, the National Institute of Epidemiology, and others.

These institutions are mandated by the Ministry of Health of Family Health and Welfare (MoHFW) to provide an oversight for laboratory confirmation of priority pathogens in India in a tiered manner as well as collate and analyze surveillance data for public health actions and work closely with the state governments where these institutes are located, the release added.

Medically Speaking Team

Share
Published by
Medically Speaking Team

Recent Posts

The Hidden Costs of Excessive Screen Time: How It Impacts Your Child’s Behavior and What You Can Do About It

Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…

21 hours ago

Transform Your Heart Health: Simple Everyday Diet and Lifestyle Changes for a Happier, Stronger Heart

Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…

21 hours ago

“Unraveling the Truth: Do Brain Tumours Only Affect Older Adults? Debunking Myths and Shedding Light on a Complex Condition”

This article explores the common misconception that brain tumours primarily affect older adults, revealing the…

21 hours ago

“Revolutionary Breakthrough: First-Ever Ovarian Cancer Vaccine Set to Transform Women’s Health and Combat a Silent Killer”

The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…

22 hours ago

“Battling the Monsoon Surge: Essential Strategies to Prevent Dengue and Chikungunya Infections in Delhi”

As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…

22 hours ago

NATURAL vs CHEMICAL SKINCARE: THE ESSENTIAL GUIDE TO CHOOSING WHAT’S BEST FOR YOUR SKIN

Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…

22 hours ago